| 0 |
CROSSMATCH INCOMPATIBLE |
45 |
0.7031 |
| 1 |
COOMBS INDIRECT TEST POSITIVE |
39 |
0.5270 |
| 2 |
BLOOD STEM CELL HARVEST |
16 |
0.4324 |
| 3 |
PLASMA CELL MYELOMA REFRACTORY |
573 |
0.4283 |
| 4 |
AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT |
25 |
0.2809 |
| 5 |
PSEUDOMYOPIA |
29 |
0.2500 |
| 6 |
PLASMA CELL LEUKAEMIA |
128 |
0.2133 |
| 7 |
LIGHT CHAIN DISEASE |
30 |
0.2069 |
| 8 |
PRIMARY AMYLOIDOSIS |
48 |
0.1868 |
| 9 |
MONOCLONAL IMMUNOGLOBULIN INCREASED |
50 |
0.1748 |
| 10 |
NATURAL KILLER CELL COUNT DECREASED |
16 |
0.1739 |
| 11 |
IVTH NERVE PARALYSIS |
39 |
0.1646 |
| 12 |
METAPNEUMOVIRUS PNEUMONIA |
15 |
0.1562 |
| 13 |
LIGHT CHAIN ANALYSIS ABNORMAL |
31 |
0.1490 |
| 14 |
ACUTE MYOPIA |
26 |
0.1429 |
| 15 |
BLOOD STEM CELL HARVEST FAILURE |
21 |
0.1419 |
| 16 |
LIGHT CHAIN ANALYSIS INCREASED |
146 |
0.1413 |
| 17 |
PLASMACYTOMA |
260 |
0.1396 |
| 18 |
ASPIRATION BONE MARROW |
18 |
0.1353 |
| 19 |
ADMINISTRATION RELATED REACTION |
25 |
0.1282 |
| 20 |
PLASMA CELL MYELOMA RECURRENT |
371 |
0.1141 |
| 21 |
PLASMA CELL MYELOMA |
4384 |
0.1123 |
| 22 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
71 |
0.0934 |
| 23 |
MENINGITIS LISTERIA |
47 |
0.0922 |
| 24 |
PNEUMONIA PARAINFLUENZAE VIRAL |
15 |
0.0882 |
| 25 |
STEM CELL TRANSPLANT |
215 |
0.0860 |
| 26 |
LISTERIA SEPSIS |
20 |
0.0758 |
| 27 |
PARAPROTEINAEMIA |
21 |
0.0677 |
| 28 |
PLASMABLASTIC LYMPHOMA |
23 |
0.0642 |
| 29 |
OSTEOLYSIS |
129 |
0.0630 |
| 30 |
MORGANELLA INFECTION |
18 |
0.0614 |
| 31 |
HYPOGAMMAGLOBULINAEMIA |
398 |
0.0605 |
| 32 |
BLOOD IMMUNOGLOBULIN A DECREASED |
39 |
0.0599 |
| 33 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
50 |
0.0593 |
| 34 |
DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION |
21 |
0.0579 |
| 35 |
CARDIAC AMYLOIDOSIS |
58 |
0.0527 |
| 36 |
TRANSPLANT |
122 |
0.0513 |
| 37 |
BODY DYSMORPHIC DISORDER |
19 |
0.0507 |
| 38 |
PNEUMOCOCCAL SEPSIS |
33 |
0.0502 |
| 39 |
PARAINFLUENZAE VIRUS INFECTION |
75 |
0.0492 |
| 40 |
MONOCLONAL GAMMOPATHY |
30 |
0.0478 |
| 41 |
PNEUMONIA HAEMOPHILUS |
23 |
0.0473 |
| 42 |
VISCERAL LEISHMANIASIS |
34 |
0.0471 |
| 43 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
205 |
0.0464 |
| 44 |
INFUSION RELATED REACTION |
3006 |
0.0453 |
| 45 |
COOMBS DIRECT TEST POSITIVE |
14 |
0.0449 |
| 46 |
POLYNEUROPATHY |
536 |
0.0447 |
| 47 |
BONE MARROW TRANSPLANT |
83 |
0.0437 |
| 48 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
35 |
0.0431 |
| 49 |
MINIMAL RESIDUAL DISEASE |
20 |
0.0414 |
| 50 |
PNEUMONIA PNEUMOCOCCAL |
60 |
0.0405 |
| 51 |
PNEUMONIA INFLUENZAL |
48 |
0.0403 |
| 52 |
FEBRILE INFECTION |
47 |
0.0399 |
| 53 |
BLOOD IMMUNOGLOBULIN A INCREASED |
21 |
0.0390 |
| 54 |
CYTOPENIA |
452 |
0.0369 |
| 55 |
BONE LESION |
122 |
0.0338 |
| 56 |
COVID-19 PNEUMONIA |
399 |
0.0338 |
| 57 |
CEREBRAL TOXOPLASMOSIS |
31 |
0.0332 |
| 58 |
AMYLOIDOSIS |
57 |
0.0330 |
| 59 |
BLOOD IMMUNOGLOBULIN M DECREASED |
33 |
0.0329 |
| 60 |
LISTERIOSIS |
34 |
0.0307 |
| 61 |
IMMUNOGLOBULINS DECREASED |
41 |
0.0298 |
| 62 |
TUMOUR LYSIS SYNDROME |
256 |
0.0291 |
| 63 |
GASTROENTERITIS SALMONELLA |
24 |
0.0288 |
| 64 |
HERPES ZOSTER DISSEMINATED |
23 |
0.0286 |
| 65 |
HUMAN POLYOMAVIRUS INFECTION |
15 |
0.0282 |
| 66 |
BLOOD IMMUNOGLOBULIN G DECREASED |
69 |
0.0278 |
| 67 |
LABORATORY TEST INTERFERENCE |
21 |
0.0267 |
| 68 |
IGA NEPHROPATHY |
44 |
0.0265 |
| 69 |
INTERVERTEBRAL DISCITIS |
50 |
0.0265 |
| 70 |
JOINT ANKYLOSIS |
15 |
0.0264 |
| 71 |
CYTOMEGALOVIRUS CHORIORETINITIS |
51 |
0.0261 |
| 72 |
MEASLES |
14 |
0.0260 |
| 73 |
H1N1 INFLUENZA |
35 |
0.0249 |
| 74 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
19 |
0.0247 |
| 75 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
31 |
0.0247 |
| 76 |
JC VIRUS INFECTION |
38 |
0.0238 |
| 77 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
14 |
0.0237 |
| 78 |
PNEUMONIA CYTOMEGALOVIRAL |
46 |
0.0237 |
| 79 |
HAEMOPHILUS INFECTION |
23 |
0.0234 |
| 80 |
INJECTION RELATED REACTION |
38 |
0.0230 |
| 81 |
PULMONARY SEPSIS |
33 |
0.0227 |
| 82 |
GRANULOCYTE COUNT DECREASED |
42 |
0.0226 |
| 83 |
PERIPHERAL SENSORY NEUROPATHY |
131 |
0.0224 |
| 84 |
RENAL VEIN THROMBOSIS |
15 |
0.0222 |
| 85 |
RESPIRATORY TRACT INFECTION VIRAL |
51 |
0.0219 |
| 86 |
NASAL OBSTRUCTION |
41 |
0.0218 |
| 87 |
ENDOCARDITIS BACTERIAL |
17 |
0.0216 |
| 88 |
LYMPHOPENIA |
304 |
0.0215 |
| 89 |
SECONDARY IMMUNODEFICIENCY |
26 |
0.0214 |
| 90 |
ESCHERICHIA SEPSIS |
62 |
0.0214 |
| 91 |
CHOROIDAL EFFUSION |
17 |
0.0212 |
| 92 |
THERAPY PARTIAL RESPONDER |
327 |
0.0209 |
| 93 |
HEPATITIS E |
33 |
0.0209 |
| 94 |
STEROID DIABETES |
31 |
0.0207 |
| 95 |
METAPNEUMOVIRUS INFECTION |
16 |
0.0204 |
| 96 |
OCULAR TOXICITY |
22 |
0.0199 |
| 97 |
PATHOLOGICAL FRACTURE |
101 |
0.0199 |
| 98 |
AUTONOMIC NEUROPATHY |
20 |
0.0197 |
| 99 |
NEUTROPENIA |
2672 |
0.0196 |
| 100 |
BACTERIAL SEPSIS |
63 |
0.0193 |
| 101 |
DEVICE RELATED THROMBOSIS |
19 |
0.0193 |
| 102 |
BK VIRUS INFECTION |
65 |
0.0193 |
| 103 |
CYTOKINE RELEASE SYNDROME |
382 |
0.0190 |
| 104 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
25 |
0.0190 |
| 105 |
CEREBRAL VENOUS SINUS THROMBOSIS |
16 |
0.0189 |
| 106 |
HYPERPYREXIA |
80 |
0.0189 |
| 107 |
MYELOSUPPRESSION |
675 |
0.0187 |
| 108 |
ESCHERICHIA BACTERAEMIA |
44 |
0.0187 |
| 109 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
14 |
0.0183 |
| 110 |
ABDOMINAL SEPSIS |
16 |
0.0182 |
| 111 |
TROPONIN T INCREASED |
23 |
0.0181 |
| 112 |
PNEUMONIA LEGIONELLA |
29 |
0.0181 |
| 113 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
25 |
0.0178 |
| 114 |
HAEMATOTOXICITY |
168 |
0.0177 |
| 115 |
NEUROPATHY PERIPHERAL |
1670 |
0.0175 |
| 116 |
FEBRILE BONE MARROW APLASIA |
74 |
0.0174 |
| 117 |
DEVICE RELATED SEPSIS |
35 |
0.0174 |
| 118 |
MASTOIDITIS |
17 |
0.0173 |
| 119 |
INFECTIOUS PLEURAL EFFUSION |
26 |
0.0171 |
| 120 |
CYTOMEGALOVIRUS VIRAEMIA |
76 |
0.0171 |
| 121 |
CYTOMEGALOVIRUS TEST POSITIVE |
30 |
0.0168 |
| 122 |
DILATED CARDIOMYOPATHY |
17 |
0.0168 |
| 123 |
VARICELLA |
40 |
0.0167 |
| 124 |
THROMBOTIC MICROANGIOPATHY |
162 |
0.0166 |
| 125 |
INFECTION REACTIVATION |
19 |
0.0166 |
| 126 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
15 |
0.0166 |
| 127 |
ACINETOBACTER INFECTION |
18 |
0.0164 |
| 128 |
NEUTROPHIL COUNT DECREASED |
655 |
0.0161 |
| 129 |
DIVERTICULAR PERFORATION |
33 |
0.0160 |
| 130 |
THROMBOCYTOPENIA |
1791 |
0.0160 |
| 131 |
CYTOMEGALOVIRUS INFECTION |
265 |
0.0159 |
| 132 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
131 |
0.0159 |
| 133 |
KERATOPATHY |
25 |
0.0158 |
| 134 |
HYPERCALCAEMIA |
191 |
0.0155 |
| 135 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
154 |
0.0153 |
| 136 |
INTRADUCTAL PROLIFERATIVE BREAST LESION |
19 |
0.0152 |
| 137 |
SQUAMOUS CELL CARCINOMA OF SKIN |
91 |
0.0151 |
| 138 |
FEBRILE NEUTROPENIA |
989 |
0.0149 |
| 139 |
RESPIRATORY TRACT INFECTION |
388 |
0.0149 |
| 140 |
CONJUNCTIVAL OEDEMA |
15 |
0.0146 |
| 141 |
VACCINATION FAILURE |
24 |
0.0144 |
| 142 |
SPINAL CORD COMPRESSION |
56 |
0.0144 |
| 143 |
APLASIA |
28 |
0.0143 |
| 144 |
ADENOCARCINOMA OF COLON |
26 |
0.0139 |
| 145 |
HYPOPROTEINAEMIA |
26 |
0.0137 |
| 146 |
SALMONELLOSIS |
23 |
0.0136 |
| 147 |
RHINOVIRUS INFECTION |
53 |
0.0136 |
| 148 |
PERIPHERAL MOTOR NEUROPATHY |
19 |
0.0136 |
| 149 |
BRONCHOPULMONARY ASPERGILLOSIS |
105 |
0.0135 |
| 150 |
CUTANEOUS T-CELL LYMPHOMA |
17 |
0.0135 |
| 151 |
PNEUMONIA VIRAL |
43 |
0.0135 |
| 152 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
38 |
0.0134 |
| 153 |
SINUS NODE DYSFUNCTION |
24 |
0.0131 |
| 154 |
DERMATITIS EXFOLIATIVE GENERALISED |
45 |
0.0129 |
| 155 |
LEUKOENCEPHALOPATHY |
48 |
0.0129 |
| 156 |
MYELODYSPLASTIC SYNDROME |
185 |
0.0128 |
| 157 |
PNEUMONIA STAPHYLOCOCCAL |
25 |
0.0127 |
| 158 |
PNEUMOCYSTIS JIROVECII INFECTION |
15 |
0.0126 |
| 159 |
BRONCHOSPASM |
179 |
0.0125 |
| 160 |
ATRIAL FLUTTER |
100 |
0.0125 |
| 161 |
BLOOD IMMUNOGLOBULIN G INCREASED |
15 |
0.0123 |
| 162 |
TRANSITIONAL CELL CARCINOMA |
16 |
0.0123 |
| 163 |
POTENTIATING DRUG INTERACTION |
41 |
0.0122 |
| 164 |
HEPATITIS B REACTIVATION |
38 |
0.0120 |
| 165 |
BACTERAEMIA |
139 |
0.0117 |
| 166 |
PSEUDOMEMBRANOUS COLITIS |
26 |
0.0116 |
| 167 |
TACHYPNOEA |
158 |
0.0116 |
| 168 |
NORMOCYTIC ANAEMIA |
17 |
0.0116 |
| 169 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
27 |
0.0115 |
| 170 |
SOFT TISSUE INFECTION |
21 |
0.0115 |
| 171 |
PANCYTOPENIA |
640 |
0.0114 |
| 172 |
PNEUMONIA BACTERIAL |
105 |
0.0114 |
| 173 |
NEUTROPENIC SEPSIS |
81 |
0.0113 |
| 174 |
INTENTIONAL PRODUCT USE ISSUE |
989 |
0.0113 |
| 175 |
URINARY TRACT INFECTION BACTERIAL |
28 |
0.0111 |
| 176 |
PNEUMOMEDIASTINUM |
20 |
0.0111 |
| 177 |
LEUKOPENIA |
546 |
0.0109 |
| 178 |
CYSTITIS HAEMORRHAGIC |
44 |
0.0109 |
| 179 |
MENINGITIS CRYPTOCOCCAL |
19 |
0.0109 |
| 180 |
PSEUDOMONAL SEPSIS |
19 |
0.0108 |
| 181 |
HEPATIC CYTOLYSIS |
138 |
0.0108 |
| 182 |
TROPONIN I INCREASED |
18 |
0.0108 |
| 183 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
94 |
0.0108 |
| 184 |
ENCEPHALITIS AUTOIMMUNE |
14 |
0.0106 |
| 185 |
LICHENOID KERATOSIS |
24 |
0.0105 |
| 186 |
SEPTIC SHOCK |
456 |
0.0105 |
| 187 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
15 |
0.0104 |
| 188 |
PNEUMONIA FUNGAL |
41 |
0.0104 |
| 189 |
VASCULAR DEVICE INFECTION |
47 |
0.0104 |
| 190 |
PNEUMONIA KLEBSIELLA |
19 |
0.0103 |
| 191 |
VENOUS THROMBOSIS |
40 |
0.0102 |
| 192 |
NEUTROPENIC COLITIS |
21 |
0.0101 |
| 193 |
ESCHERICHIA URINARY TRACT INFECTION |
43 |
0.0101 |
| 194 |
CYTOMEGALOVIRUS COLITIS |
23 |
0.0100 |
| 195 |
SUDDEN HEARING LOSS |
20 |
0.0099 |
| 196 |
SPINAL COLUMN INJURY |
22 |
0.0099 |
| 197 |
ACUTE PULMONARY OEDEMA |
55 |
0.0098 |
| 198 |
THROMBOPHLEBITIS |
34 |
0.0097 |
| 199 |
WHITE BLOOD CELL COUNT DECREASED |
1051 |
0.0097 |
| 200 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
92 |
0.0096 |
| 201 |
RECTAL ABSCESS |
16 |
0.0095 |
| 202 |
PLATELET COUNT DECREASED |
1013 |
0.0095 |
| 203 |
ILEUS PARALYTIC |
42 |
0.0094 |
| 204 |
TEMPERATURE INTOLERANCE |
97 |
0.0094 |
| 205 |
ENDOCARDITIS |
48 |
0.0093 |
| 206 |
APLASIA PURE RED CELL |
32 |
0.0093 |
| 207 |
VARICELLA ZOSTER VIRUS INFECTION |
19 |
0.0092 |
| 208 |
ATYPICAL PNEUMONIA |
27 |
0.0090 |
| 209 |
EXTRAVASATION |
37 |
0.0090 |
| 210 |
FULL BLOOD COUNT DECREASED |
179 |
0.0089 |
| 211 |
HYPOCALCAEMIA |
167 |
0.0088 |
| 212 |
GASTROINTESTINAL TOXICITY |
42 |
0.0087 |
| 213 |
VENOUS THROMBOSIS LIMB |
18 |
0.0087 |
| 214 |
ASPHYXIA |
71 |
0.0087 |
| 215 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
51 |
0.0086 |
| 216 |
ADVERSE REACTION |
114 |
0.0086 |
| 217 |
HAEMOLYSIS |
66 |
0.0085 |
| 218 |
RESPIRATORY SYMPTOM |
24 |
0.0084 |
| 219 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
215 |
0.0083 |
| 220 |
ACUTE MYELOID LEUKAEMIA |
129 |
0.0083 |
| 221 |
UROSEPSIS |
76 |
0.0082 |
| 222 |
ANGLE CLOSURE GLAUCOMA |
21 |
0.0082 |
| 223 |
NEUTROPHIL COUNT ABNORMAL |
23 |
0.0081 |
| 224 |
PARESIS |
18 |
0.0081 |
| 225 |
CARDIAC FAILURE |
647 |
0.0081 |
| 226 |
ANAEMIA |
1534 |
0.0080 |
| 227 |
ERYSIPELAS |
40 |
0.0080 |
| 228 |
EMBOLISM |
66 |
0.0079 |
| 229 |
BONE MARROW DISORDER |
24 |
0.0079 |
| 230 |
HUMERUS FRACTURE |
38 |
0.0079 |
| 231 |
RASH MACULO-PAPULAR |
175 |
0.0079 |
| 232 |
GUILLAIN-BARRE SYNDROME |
38 |
0.0078 |
| 233 |
PNEUMONIA |
2511 |
0.0077 |
| 234 |
ACUTE RESPIRATORY FAILURE |
149 |
0.0077 |
| 235 |
KLEBSIELLA INFECTION |
39 |
0.0077 |
| 236 |
DISEASE PROGRESSION |
909 |
0.0077 |
| 237 |
SEPSIS |
854 |
0.0076 |
| 238 |
CLOSTRIDIUM DIFFICILE COLITIS |
81 |
0.0076 |
| 239 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
216 |
0.0076 |
| 240 |
CARDIAC FAILURE ACUTE |
50 |
0.0075 |
| 241 |
CANCER PAIN |
19 |
0.0074 |
| 242 |
COVID-19 |
1303 |
0.0074 |
| 243 |
GASTROINTESTINAL INFECTION |
66 |
0.0074 |
| 244 |
HAEMOLYTIC URAEMIC SYNDROME |
17 |
0.0073 |
| 245 |
MUCORMYCOSIS |
19 |
0.0073 |
| 246 |
IMMUNE-MEDIATED MYOSITIS |
20 |
0.0072 |
| 247 |
TOXIC SKIN ERUPTION |
73 |
0.0072 |
| 248 |
ADENOVIRUS INFECTION |
21 |
0.0072 |
| 249 |
LUMBAR VERTEBRAL FRACTURE |
33 |
0.0072 |
| 250 |
STAPHYLOCOCCAL BACTERAEMIA |
31 |
0.0071 |
| 251 |
INFECTION |
1029 |
0.0071 |
| 252 |
WHITE BLOOD CELL DISORDER |
19 |
0.0071 |
| 253 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
55 |
0.0071 |
| 254 |
INFUSION SITE EXTRAVASATION |
44 |
0.0071 |
| 255 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
27 |
0.0071 |
| 256 |
PNEUMONITIS |
192 |
0.0070 |
| 257 |
BONE MARROW FAILURE |
143 |
0.0070 |
| 258 |
PHYSICAL DECONDITIONING |
18 |
0.0070 |
| 259 |
LARYNGEAL OEDEMA |
43 |
0.0070 |
| 260 |
TROPONIN INCREASED |
53 |
0.0070 |
| 261 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
52 |
0.0069 |
| 262 |
STAPHYLOCOCCAL SEPSIS |
34 |
0.0069 |
| 263 |
LABORATORY TEST ABNORMAL |
203 |
0.0069 |
| 264 |
STRESS CARDIOMYOPATHY |
40 |
0.0069 |
| 265 |
ATRIAL FIBRILLATION |
662 |
0.0068 |
| 266 |
THORACIC VERTEBRAL FRACTURE |
20 |
0.0068 |
| 267 |
UPPER RESPIRATORY TRACT INFECTION |
310 |
0.0067 |
| 268 |
LEFT VENTRICULAR FAILURE |
23 |
0.0067 |
| 269 |
HEPATITIS B |
40 |
0.0066 |
| 270 |
HAEMATOLOGICAL INFECTION |
16 |
0.0065 |
| 271 |
OESOPHAGEAL CANDIDIASIS |
26 |
0.0065 |
| 272 |
APLASTIC ANAEMIA |
34 |
0.0065 |
| 273 |
ENCEPHALITIS |
45 |
0.0065 |
| 274 |
ISCHAEMIC STROKE |
116 |
0.0065 |
| 275 |
CHILLS |
761 |
0.0065 |
| 276 |
ARTERIOSPASM CORONARY |
26 |
0.0065 |
| 277 |
HYPERTENSIVE CRISIS |
72 |
0.0065 |
| 278 |
GASTROENTERITIS |
94 |
0.0064 |
| 279 |
EPSTEIN-BARR VIRUS INFECTION |
40 |
0.0064 |
| 280 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
17 |
0.0064 |
| 281 |
CORONAVIRUS INFECTION |
42 |
0.0063 |
| 282 |
COMPRESSION FRACTURE |
34 |
0.0063 |
| 283 |
HYPERURICAEMIA |
26 |
0.0063 |
| 284 |
MIXED LIVER INJURY |
19 |
0.0063 |
| 285 |
ASPERGILLUS INFECTION |
41 |
0.0062 |
| 286 |
GASTRIC PERFORATION |
17 |
0.0062 |
| 287 |
EOSINOPHILIA |
109 |
0.0062 |
| 288 |
HYPOKALAEMIA |
286 |
0.0062 |
| 289 |
TOXIC ENCEPHALOPATHY |
31 |
0.0061 |
| 290 |
ORAL PRURITUS |
14 |
0.0061 |
| 291 |
HEPATITIS FULMINANT |
18 |
0.0061 |
| 292 |
BLOOD DISORDER |
48 |
0.0060 |
| 293 |
PULMONARY TOXICITY |
42 |
0.0059 |
| 294 |
HYPERVOLAEMIA |
29 |
0.0059 |
| 295 |
NOCARDIOSIS |
15 |
0.0059 |
| 296 |
SQUAMOUS CELL CARCINOMA |
55 |
0.0058 |
| 297 |
SPINAL COMPRESSION FRACTURE |
48 |
0.0058 |
| 298 |
DEEP VEIN THROMBOSIS |
376 |
0.0058 |
| 299 |
IMMUNOSUPPRESSION |
51 |
0.0058 |
| 300 |
BASAL CELL CARCINOMA |
90 |
0.0058 |
| 301 |
SUDDEN DEATH |
61 |
0.0058 |
| 302 |
NEOPLASM |
66 |
0.0057 |
| 303 |
NON-CARDIAC CHEST PAIN |
18 |
0.0057 |
| 304 |
LUNG ADENOCARCINOMA |
17 |
0.0056 |
| 305 |
EMBOLISM VENOUS |
17 |
0.0056 |
| 306 |
LYMPHOCYTE COUNT DECREASED |
99 |
0.0056 |
| 307 |
DUODENAL ULCER HAEMORRHAGE |
16 |
0.0056 |
| 308 |
RETINAL VEIN OCCLUSION |
16 |
0.0056 |
| 309 |
HYPOXIA |
196 |
0.0056 |
| 310 |
ILEUS |
69 |
0.0055 |
| 311 |
SPINAL PAIN |
65 |
0.0055 |
| 312 |
NEPHROTIC SYNDROME |
38 |
0.0055 |
| 313 |
ENCEPHALOPATHY |
135 |
0.0055 |
| 314 |
HAEMOLYTIC ANAEMIA |
49 |
0.0055 |
| 315 |
FEMORAL NECK FRACTURE |
28 |
0.0055 |
| 316 |
RESPIRATORY FAILURE |
397 |
0.0054 |
| 317 |
ACUTE CORONARY SYNDROME |
45 |
0.0054 |
| 318 |
HYPOALBUMINAEMIA |
42 |
0.0054 |
| 319 |
ORTHOSTATIC HYPOTENSION |
94 |
0.0054 |
| 320 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
19 |
0.0054 |
| 321 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
95 |
0.0054 |
| 322 |
HYPERTHERMIA |
41 |
0.0054 |
| 323 |
RESPIRATORY DISTRESS |
148 |
0.0054 |
| 324 |
TRANSFUSION |
56 |
0.0053 |
| 325 |
DRUG TOLERANCE DECREASED |
15 |
0.0053 |
| 326 |
MUSCULOSKELETAL CHEST PAIN |
82 |
0.0053 |
| 327 |
CHOLECYSTITIS ACUTE |
30 |
0.0053 |
| 328 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
25 |
0.0053 |
| 329 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
18 |
0.0052 |
| 330 |
ORGANISING PNEUMONIA |
26 |
0.0052 |
| 331 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
16 |
0.0052 |
| 332 |
DECUBITUS ULCER |
42 |
0.0051 |
| 333 |
PULMONARY EMBOLISM |
485 |
0.0051 |
| 334 |
MALNUTRITION |
57 |
0.0051 |
| 335 |
ANXIETY DISORDER |
17 |
0.0051 |
| 336 |
PYELONEPHRITIS |
44 |
0.0051 |
| 337 |
BACTERIAL INFECTION |
94 |
0.0050 |
| 338 |
ACUTE KIDNEY INJURY |
767 |
0.0050 |
| 339 |
SUDDEN CARDIAC DEATH |
17 |
0.0050 |
| 340 |
PARTIAL SEIZURES |
26 |
0.0050 |
| 341 |
THERAPY NON-RESPONDER |
223 |
0.0050 |
| 342 |
SKIN TOXICITY |
28 |
0.0049 |
| 343 |
MALIGNANT MELANOMA |
66 |
0.0049 |
| 344 |
OXYGEN SATURATION DECREASED |
276 |
0.0049 |
| 345 |
PYREXIA |
1699 |
0.0049 |
| 346 |
NEUROTOXICITY |
86 |
0.0049 |
| 347 |
HYPOPHOSPHATAEMIA |
36 |
0.0049 |
| 348 |
SUSPECTED COVID-19 |
16 |
0.0048 |
| 349 |
OSTEONECROSIS OF JAW |
120 |
0.0048 |
| 350 |
OTITIS MEDIA |
16 |
0.0048 |
| 351 |
TASTE DISORDER |
98 |
0.0048 |
| 352 |
LARGE INTESTINE PERFORATION |
33 |
0.0047 |
| 353 |
IRIDOCYCLITIS |
15 |
0.0047 |
| 354 |
CARDIOTOXICITY |
42 |
0.0047 |
| 355 |
AORTIC VALVE INCOMPETENCE |
20 |
0.0047 |
| 356 |
CLAVICLE FRACTURE |
18 |
0.0047 |
| 357 |
INCORRECT DRUG ADMINISTRATION RATE |
20 |
0.0047 |
| 358 |
MENINGITIS ASEPTIC |
21 |
0.0047 |
| 359 |
CUTANEOUS VASCULITIS |
17 |
0.0047 |
| 360 |
MENINGITIS |
31 |
0.0046 |
| 361 |
OFF LABEL USE |
4059 |
0.0046 |
| 362 |
HORDEOLUM |
20 |
0.0046 |
| 363 |
HYPOMAGNESAEMIA |
64 |
0.0046 |
| 364 |
LOWER RESPIRATORY TRACT INFECTION |
208 |
0.0046 |
| 365 |
PRODUCT PREPARATION ISSUE |
30 |
0.0046 |
| 366 |
EJECTION FRACTION DECREASED |
71 |
0.0046 |
| 367 |
CARDIAC DYSFUNCTION |
17 |
0.0046 |
| 368 |
ESCHERICHIA INFECTION |
37 |
0.0045 |
| 369 |
CHOLESTASIS |
86 |
0.0045 |
| 370 |
PSEUDOMONAS INFECTION |
38 |
0.0044 |
| 371 |
OROPHARYNGEAL DISCOMFORT |
40 |
0.0044 |
| 372 |
SUSPECTED OFF LABEL USE |
20 |
0.0044 |
| 373 |
CLOSTRIDIUM DIFFICILE INFECTION |
96 |
0.0044 |
| 374 |
MUCOSAL INFLAMMATION |
115 |
0.0044 |
| 375 |
ARTHRITIS BACTERIAL |
18 |
0.0044 |
| 376 |
IMMUNE THROMBOCYTOPENIA |
20 |
0.0044 |
| 377 |
GENERALISED OEDEMA |
54 |
0.0044 |
| 378 |
LEFT VENTRICULAR DYSFUNCTION |
29 |
0.0043 |
| 379 |
HEPATOCELLULAR INJURY |
61 |
0.0043 |
| 380 |
PULMONARY OEDEMA |
192 |
0.0043 |
| 381 |
INTERSTITIAL LUNG DISEASE |
207 |
0.0043 |
| 382 |
BRONCHIOLITIS |
15 |
0.0043 |
| 383 |
DEAFNESS NEUROSENSORY |
14 |
0.0043 |
| 384 |
PROTEIN TOTAL DECREASED |
16 |
0.0042 |
| 385 |
FACIAL PARALYSIS |
36 |
0.0042 |
| 386 |
BONE PAIN |
245 |
0.0042 |
| 387 |
SARS-COV-2 TEST POSITIVE |
55 |
0.0042 |
| 388 |
PERIPHERAL ISCHAEMIA |
17 |
0.0042 |
| 389 |
IMMUNODEFICIENCY |
62 |
0.0042 |
| 390 |
ENTEROCOLITIS |
24 |
0.0042 |
| 391 |
HICCUPS |
34 |
0.0041 |
| 392 |
CARDIOGENIC SHOCK |
59 |
0.0041 |
| 393 |
HERPES ZOSTER |
236 |
0.0041 |
| 394 |
MYOCARDITIS |
47 |
0.0041 |
| 395 |
INFLUENZA |
457 |
0.0041 |
| 396 |
ORAL INFECTION |
16 |
0.0041 |
| 397 |
RHINITIS |
33 |
0.0041 |
| 398 |
AGRANULOCYTOSIS |
76 |
0.0041 |
| 399 |
BENIGN PROSTATIC HYPERPLASIA |
21 |
0.0041 |
| 400 |
BLOOD CREATININE ABNORMAL |
14 |
0.0040 |
| 401 |
FAILURE TO THRIVE |
21 |
0.0040 |
| 402 |
PLEURISY |
24 |
0.0040 |
| 403 |
HYPOPNOEA |
14 |
0.0040 |
| 404 |
BRONCHITIS |
298 |
0.0040 |
| 405 |
RED BLOOD CELL COUNT DECREASED |
115 |
0.0040 |
| 406 |
AORTIC STENOSIS |
14 |
0.0040 |
| 407 |
JAUNDICE CHOLESTATIC |
14 |
0.0040 |
| 408 |
PLEURAL EFFUSION |
241 |
0.0040 |
| 409 |
RENAL IMPAIRMENT |
332 |
0.0039 |
| 410 |
SINUS TACHYCARDIA |
56 |
0.0039 |
| 411 |
DIVERTICULITIS |
109 |
0.0039 |
| 412 |
DRUG INTOLERANCE |
378 |
0.0039 |
| 413 |
ARTHRITIS INFECTIVE |
18 |
0.0039 |
| 414 |
PERFORMANCE STATUS DECREASED |
18 |
0.0039 |
| 415 |
THROMBOSIS |
310 |
0.0038 |
| 416 |
HYPERGLYCAEMIA |
140 |
0.0038 |
| 417 |
INFLAMMATORY MARKER INCREASED |
19 |
0.0038 |
| 418 |
BLOOD CALCIUM DECREASED |
43 |
0.0038 |
| 419 |
CONSTIPATION |
833 |
0.0038 |
| 420 |
HEPATOTOXICITY |
84 |
0.0038 |
| 421 |
HYPOVOLAEMIC SHOCK |
18 |
0.0038 |
| 422 |
CARDIAC FAILURE CHRONIC |
16 |
0.0038 |
| 423 |
CHRONIC SINUSITIS |
14 |
0.0037 |
| 424 |
CHEST DISCOMFORT |
380 |
0.0037 |
| 425 |
MITRAL VALVE INCOMPETENCE |
42 |
0.0037 |
| 426 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
262 |
0.0037 |
| 427 |
APPENDICITIS |
34 |
0.0036 |
| 428 |
HAEMOGLOBIN DECREASED |
372 |
0.0036 |
| 429 |
RENAL FAILURE |
479 |
0.0036 |
| 430 |
RIB FRACTURE |
74 |
0.0036 |
| 431 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
57 |
0.0036 |
| 432 |
ENTERITIS |
23 |
0.0036 |
| 433 |
HYPERTRIGLYCERIDAEMIA |
21 |
0.0036 |
| 434 |
COLITIS ISCHAEMIC |
24 |
0.0036 |
| 435 |
COLITIS |
134 |
0.0035 |
| 436 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
18 |
0.0035 |
| 437 |
NEUROLOGICAL SYMPTOM |
20 |
0.0035 |
| 438 |
PRESYNCOPE |
85 |
0.0035 |
| 439 |
LUNG DISORDER |
171 |
0.0035 |
| 440 |
HAEMORRHOIDAL HAEMORRHAGE |
17 |
0.0035 |
| 441 |
INTERCEPTED MEDICATION ERROR |
16 |
0.0034 |
| 442 |
CELLULITIS |
174 |
0.0034 |
| 443 |
ADVERSE EVENT |
318 |
0.0034 |
| 444 |
DRUG ERUPTION |
61 |
0.0034 |
| 445 |
FRACTURE |
65 |
0.0034 |
| 446 |
SYNCOPE |
342 |
0.0034 |
| 447 |
DISSEMINATED INTRAVASCULAR COAGULATION |
48 |
0.0034 |
| 448 |
SPINAL FRACTURE |
68 |
0.0034 |
| 449 |
DEVICE RELATED INFECTION |
52 |
0.0034 |
| 450 |
VENTRICULAR EXTRASYSTOLES |
35 |
0.0034 |
| 451 |
SECOND PRIMARY MALIGNANCY |
28 |
0.0034 |
| 452 |
CHOLECYSTITIS |
40 |
0.0034 |
| 453 |
DIARRHOEA |
2161 |
0.0033 |
| 454 |
ACUTE MYOCARDIAL INFARCTION |
98 |
0.0033 |
| 455 |
PRODUCT PREPARATION ERROR |
68 |
0.0033 |
| 456 |
URINARY TRACT INFECTION |
564 |
0.0033 |
| 457 |
IMMUNE SYSTEM DISORDER |
43 |
0.0033 |
| 458 |
DECREASED IMMUNE RESPONSIVENESS |
32 |
0.0033 |
| 459 |
TONSILLITIS |
17 |
0.0033 |
| 460 |
DELIRIUM |
113 |
0.0033 |
| 461 |
BRAIN FOG |
51 |
0.0033 |
| 462 |
CHOLANGITIS |
20 |
0.0032 |
| 463 |
MONOPLEGIA |
14 |
0.0032 |
| 464 |
PULMONARY HAEMORRHAGE |
25 |
0.0032 |
| 465 |
BLOOD CALCIUM INCREASED |
28 |
0.0032 |
| 466 |
ANAPHYLACTIC REACTION |
176 |
0.0032 |
| 467 |
ELECTROLYTE IMBALANCE |
37 |
0.0032 |
| 468 |
CARDIOMYOPATHY |
47 |
0.0032 |
| 469 |
PARKINSONISM |
31 |
0.0032 |
| 470 |
SKIN ABRASION |
15 |
0.0032 |
| 471 |
SNEEZING |
71 |
0.0032 |
| 472 |
HEPATITIS CHOLESTATIC |
19 |
0.0032 |
| 473 |
GINGIVITIS |
17 |
0.0031 |
| 474 |
TRANSAMINASES INCREASED |
70 |
0.0031 |
| 475 |
TRICUSPID VALVE INCOMPETENCE |
25 |
0.0031 |
| 476 |
BLOOD CREATININE INCREASED |
205 |
0.0031 |
| 477 |
BONE DISORDER |
57 |
0.0031 |
| 478 |
SKIN INFECTION |
35 |
0.0031 |
| 479 |
SENSITIVE SKIN |
23 |
0.0031 |
| 480 |
GENERAL PHYSICAL HEALTH DETERIORATION |
360 |
0.0031 |
| 481 |
RESPIRATORY DISORDER |
93 |
0.0031 |
| 482 |
ENTEROCOCCAL INFECTION |
15 |
0.0031 |
| 483 |
HEPATIC FUNCTION ABNORMAL |
115 |
0.0031 |
| 484 |
THROAT IRRITATION |
138 |
0.0031 |
| 485 |
OEDEMA |
164 |
0.0030 |
| 486 |
HAEMODYNAMIC INSTABILITY |
23 |
0.0030 |
| 487 |
GOUT |
54 |
0.0030 |
| 488 |
BLOOD TEST ABNORMAL |
42 |
0.0030 |
| 489 |
RHINORRHOEA |
193 |
0.0030 |
| 490 |
ANAL ABSCESS |
16 |
0.0030 |
| 491 |
DIALYSIS |
42 |
0.0030 |
| 492 |
INGUINAL HERNIA |
18 |
0.0030 |
| 493 |
MENTAL STATUS CHANGES |
82 |
0.0029 |
| 494 |
INTESTINAL PERFORATION |
33 |
0.0029 |
| 495 |
FULL BLOOD COUNT ABNORMAL |
31 |
0.0029 |
| 496 |
PHLEBITIS |
15 |
0.0029 |
| 497 |
TACHYCARDIA |
260 |
0.0029 |
| 498 |
PNEUMONIA ASPIRATION |
73 |
0.0029 |
| 499 |
NEURALGIA |
71 |
0.0029 |
| 500 |
VIRAL INFECTION |
97 |
0.0029 |
| 501 |
COUGH |
815 |
0.0029 |
| 502 |
DYSPNOEA |
1644 |
0.0029 |
| 503 |
HYPERBILIRUBINAEMIA |
30 |
0.0029 |
| 504 |
STREPTOCOCCAL INFECTION |
16 |
0.0029 |
| 505 |
BACK PAIN |
666 |
0.0029 |
| 506 |
PULMONARY ALVEOLAR HAEMORRHAGE |
16 |
0.0028 |
| 507 |
PANCREATITIS ACUTE |
64 |
0.0028 |
| 508 |
PELVIC FRACTURE |
22 |
0.0028 |
| 509 |
NASAL CONGESTION |
166 |
0.0028 |
| 510 |
RESPIRATORY RATE INCREASED |
25 |
0.0028 |
| 511 |
PERICARDIAL EFFUSION |
65 |
0.0028 |
| 512 |
NERVOUS SYSTEM DISORDER |
87 |
0.0028 |
| 513 |
CORONARY ARTERY STENOSIS |
14 |
0.0028 |
| 514 |
GRAFT VERSUS HOST DISEASE |
20 |
0.0028 |
| 515 |
WHEEZING |
163 |
0.0027 |
| 516 |
LIVER FUNCTION TEST INCREASED |
59 |
0.0027 |
| 517 |
FATIGUE |
2138 |
0.0027 |
| 518 |
HAEMORRHAGE INTRACRANIAL |
41 |
0.0027 |
| 519 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
47 |
0.0027 |
| 520 |
OLIGURIA |
17 |
0.0027 |
| 521 |
ORAL CANDIDIASIS |
36 |
0.0027 |
| 522 |
HYPERTRANSAMINASAEMIA |
19 |
0.0027 |
| 523 |
C-REACTIVE PROTEIN INCREASED |
99 |
0.0027 |
| 524 |
SUPRAVENTRICULAR TACHYCARDIA |
26 |
0.0027 |
| 525 |
DRUG RESISTANCE |
69 |
0.0027 |
| 526 |
AGEUSIA |
67 |
0.0027 |
| 527 |
HYPERTENSION |
566 |
0.0027 |
| 528 |
FLANK PAIN |
25 |
0.0027 |
| 529 |
RASH |
1160 |
0.0027 |
| 530 |
OEDEMA PERIPHERAL |
324 |
0.0027 |
| 531 |
CARDIO-RESPIRATORY ARREST |
111 |
0.0027 |
| 532 |
SPLENOMEGALY |
31 |
0.0026 |
| 533 |
PULMONARY ARTERIAL HYPERTENSION |
38 |
0.0026 |
| 534 |
PRODUCT USE ISSUE |
490 |
0.0026 |
| 535 |
THERAPEUTIC RESPONSE DECREASED |
158 |
0.0026 |
| 536 |
HERPES VIRUS INFECTION |
15 |
0.0026 |
| 537 |
GENERALISED TONIC-CLONIC SEIZURE |
43 |
0.0026 |
| 538 |
DIFFUSE LARGE B-CELL LYMPHOMA |
20 |
0.0026 |
| 539 |
MOUTH HAEMORRHAGE |
19 |
0.0026 |
| 540 |
PHARYNGITIS |
32 |
0.0026 |
| 541 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
141 |
0.0026 |
| 542 |
PULMONARY THROMBOSIS |
28 |
0.0026 |
| 543 |
FAECALOMA |
14 |
0.0026 |
| 544 |
GASTROINTESTINAL INFLAMMATION |
20 |
0.0026 |
| 545 |
THROAT TIGHTNESS |
69 |
0.0025 |
| 546 |
COGNITIVE DISORDER |
119 |
0.0025 |
| 547 |
MYOCARDIAL ISCHAEMIA |
29 |
0.0025 |
| 548 |
LEUKAEMIA |
24 |
0.0025 |
| 549 |
ADVERSE DRUG REACTION |
227 |
0.0025 |
| 550 |
ANAPHYLACTIC SHOCK |
65 |
0.0025 |
| 551 |
TRANSIENT ISCHAEMIC ATTACK |
85 |
0.0025 |
| 552 |
CEREBRAL INFARCTION |
61 |
0.0025 |
| 553 |
SINUS BRADYCARDIA |
24 |
0.0025 |
| 554 |
CYANOSIS |
39 |
0.0025 |
| 555 |
PRODUCT DISTRIBUTION ISSUE |
23 |
0.0025 |
| 556 |
SHOCK |
57 |
0.0025 |
| 557 |
PROTEINURIA |
47 |
0.0025 |
| 558 |
HYPONATRAEMIA |
139 |
0.0025 |
| 559 |
PRODUCT USE IN UNAPPROVED INDICATION |
611 |
0.0025 |
| 560 |
NEPHROPATHY |
23 |
0.0025 |
| 561 |
BLOOD POTASSIUM DECREASED |
74 |
0.0025 |
| 562 |
CATARACT |
146 |
0.0024 |
| 563 |
HYPOTENSION |
491 |
0.0024 |
| 564 |
ASTHENIA |
919 |
0.0024 |
| 565 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
18 |
0.0024 |
| 566 |
RIGHT VENTRICULAR FAILURE |
17 |
0.0024 |
| 567 |
ADRENAL INSUFFICIENCY |
29 |
0.0024 |
| 568 |
TOOTH DISORDER |
53 |
0.0024 |
| 569 |
LUNG INFECTION |
37 |
0.0024 |
| 570 |
MUSCLE SPASMS |
437 |
0.0024 |
| 571 |
ATELECTASIS |
23 |
0.0024 |
| 572 |
PRODUCTIVE COUGH |
113 |
0.0024 |
| 573 |
GENERAL PHYSICAL CONDITION ABNORMAL |
16 |
0.0024 |
| 574 |
ARRHYTHMIA |
111 |
0.0023 |
| 575 |
RENAL DISORDER |
109 |
0.0023 |
| 576 |
GLAUCOMA |
45 |
0.0023 |
| 577 |
PRODUCT CONTAINER ISSUE |
20 |
0.0023 |
| 578 |
DECREASED APPETITE |
540 |
0.0023 |
| 579 |
FEMUR FRACTURE |
72 |
0.0023 |
| 580 |
BLOOD MAGNESIUM DECREASED |
20 |
0.0023 |
| 581 |
PLATELET COUNT ABNORMAL |
14 |
0.0023 |
| 582 |
PULMONARY HYPERTENSION |
48 |
0.0023 |
| 583 |
END STAGE RENAL DISEASE |
42 |
0.0023 |
| 584 |
SINUS CONGESTION |
31 |
0.0023 |
| 585 |
RASH PRURITIC |
123 |
0.0023 |
| 586 |
BLOOD BILIRUBIN INCREASED |
61 |
0.0023 |
| 587 |
HEPATOMEGALY |
22 |
0.0022 |
| 588 |
SPINAL DISORDER |
21 |
0.0022 |
| 589 |
ASCITES |
65 |
0.0022 |
| 590 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
115 |
0.0022 |
| 591 |
RESPIRATORY TRACT CONGESTION |
35 |
0.0022 |
| 592 |
SKIN REACTION |
31 |
0.0022 |
| 593 |
MYOPATHY |
19 |
0.0022 |
| 594 |
PULMONARY FIBROSIS |
42 |
0.0022 |
| 595 |
VENTRICULAR TACHYCARDIA |
36 |
0.0022 |
| 596 |
URINE OUTPUT DECREASED |
19 |
0.0022 |
| 597 |
ALTERED STATE OF CONSCIOUSNESS |
47 |
0.0022 |
| 598 |
SUBDURAL HAEMATOMA |
31 |
0.0022 |
| 599 |
ANGINA UNSTABLE |
14 |
0.0022 |
| 600 |
HERPES SIMPLEX |
14 |
0.0022 |
| 601 |
MASS |
30 |
0.0021 |
| 602 |
PHARYNGEAL SWELLING |
21 |
0.0021 |
| 603 |
VASCULITIS |
25 |
0.0021 |
| 604 |
EPISTAXIS |
160 |
0.0021 |
| 605 |
THERAPY CHANGE |
21 |
0.0021 |
| 606 |
CANDIDA INFECTION |
36 |
0.0021 |
| 607 |
THERAPY INTERRUPTED |
152 |
0.0021 |
| 608 |
PULMONARY CONGESTION |
28 |
0.0021 |
| 609 |
GLOMERULAR FILTRATION RATE DECREASED |
26 |
0.0021 |
| 610 |
TREMOR |
348 |
0.0021 |
| 611 |
GASTROINTESTINAL DISORDER |
186 |
0.0021 |
| 612 |
DYSPHONIA |
121 |
0.0021 |
| 613 |
SKIN DISORDER |
69 |
0.0021 |
| 614 |
BRADYCARDIA |
107 |
0.0020 |
| 615 |
PETECHIAE |
21 |
0.0020 |
| 616 |
TRANSPLANT REJECTION |
16 |
0.0020 |
| 617 |
HEPATIC FAILURE |
60 |
0.0020 |
| 618 |
ANGINA PECTORIS |
57 |
0.0020 |
| 619 |
DEATH |
1713 |
0.0020 |
| 620 |
OSTEOMYELITIS |
36 |
0.0020 |
| 621 |
BLOOD COUNT ABNORMAL |
30 |
0.0020 |
| 622 |
NERVE INJURY |
22 |
0.0020 |
| 623 |
CARDIAC ARREST |
163 |
0.0020 |
| 624 |
TOOTH INFECTION |
26 |
0.0020 |
| 625 |
HOSPITALISATION |
303 |
0.0020 |
| 626 |
NEPHROPATHY TOXIC |
22 |
0.0020 |
| 627 |
CARDIAC DISORDER |
183 |
0.0020 |
| 628 |
COLON CANCER |
29 |
0.0019 |
| 629 |
INJECTION SITE EXTRAVASATION |
24 |
0.0019 |
| 630 |
TREATMENT NONCOMPLIANCE |
106 |
0.0019 |
| 631 |
DEMENTIA |
54 |
0.0019 |
| 632 |
PERITONITIS |
40 |
0.0019 |
| 633 |
DEHYDRATION |
257 |
0.0019 |
| 634 |
HOSPICE CARE |
19 |
0.0019 |
| 635 |
HEPATIC CIRRHOSIS |
36 |
0.0019 |
| 636 |
LIVER INJURY |
47 |
0.0019 |
| 637 |
ELECTROCARDIOGRAM ABNORMAL |
15 |
0.0019 |
| 638 |
NEOPLASM PROGRESSION |
66 |
0.0019 |
| 639 |
BLOOD PRESSURE DECREASED |
126 |
0.0019 |
| 640 |
PRODUCT DOSE OMISSION ISSUE |
555 |
0.0019 |
| 641 |
PRODUCT ADMINISTRATION ERROR |
38 |
0.0019 |
| 642 |
CIRCULATORY COLLAPSE |
32 |
0.0019 |
| 643 |
EPILEPSY |
57 |
0.0019 |
| 644 |
ANURIA |
16 |
0.0019 |
| 645 |
LACRIMATION INCREASED |
56 |
0.0019 |
| 646 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
41 |
0.0018 |
| 647 |
RETINAL DETACHMENT |
17 |
0.0018 |
| 648 |
SHOCK HAEMORRHAGIC |
15 |
0.0018 |
| 649 |
ALANINE AMINOTRANSFERASE INCREASED |
113 |
0.0018 |
| 650 |
SEASONAL ALLERGY |
26 |
0.0018 |
| 651 |
POLYURIA |
15 |
0.0018 |
| 652 |
NIGHT SWEATS |
59 |
0.0018 |
| 653 |
PERIPHERAL SWELLING |
281 |
0.0018 |
| 654 |
MALIGNANT NEOPLASM PROGRESSION |
186 |
0.0018 |
| 655 |
HAEMATOMA |
47 |
0.0018 |
| 656 |
DYSPNOEA EXERTIONAL |
68 |
0.0018 |
| 657 |
NAUSEA |
1419 |
0.0018 |
| 658 |
PRODUCT PACKAGING ISSUE |
17 |
0.0018 |
| 659 |
CEREBRAL HAEMORRHAGE |
64 |
0.0018 |
| 660 |
SMALL INTESTINAL OBSTRUCTION |
22 |
0.0018 |
| 661 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
44 |
0.0018 |
| 662 |
SKIN LACERATION |
19 |
0.0017 |
| 663 |
PRODUCT PRESCRIBING ISSUE |
38 |
0.0017 |
| 664 |
BRAIN OEDEMA |
22 |
0.0017 |
| 665 |
HYPERKALAEMIA |
61 |
0.0017 |
| 666 |
IRON DEFICIENCY ANAEMIA |
16 |
0.0017 |
| 667 |
CONFUSIONAL STATE |
280 |
0.0017 |
| 668 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
29 |
0.0017 |
| 669 |
VOMITING |
803 |
0.0017 |
| 670 |
SPINAL OSTEOARTHRITIS |
15 |
0.0017 |
| 671 |
TUBULOINTERSTITIAL NEPHRITIS |
32 |
0.0017 |
| 672 |
SKIN ULCER |
44 |
0.0017 |
| 673 |
NASOPHARYNGITIS |
313 |
0.0017 |
| 674 |
SINUSITIS |
173 |
0.0017 |
| 675 |
ATAXIA |
20 |
0.0017 |
| 676 |
ASPARTATE AMINOTRANSFERASE INCREASED |
89 |
0.0017 |
| 677 |
CONJUNCTIVITIS |
31 |
0.0017 |
| 678 |
SUBARACHNOID HAEMORRHAGE |
17 |
0.0017 |
| 679 |
CHEST PAIN |
309 |
0.0017 |
| 680 |
CARDIAC FAILURE CONGESTIVE |
134 |
0.0017 |
| 681 |
STOMATITIS |
101 |
0.0017 |
| 682 |
CYSTITIS |
53 |
0.0017 |
| 683 |
FACE OEDEMA |
28 |
0.0017 |
| 684 |
HYPERSENSITIVITY |
308 |
0.0017 |
| 685 |
LOCALISED INFECTION |
40 |
0.0017 |
| 686 |
GASTRIC HAEMORRHAGE |
19 |
0.0016 |
| 687 |
FLUID OVERLOAD |
24 |
0.0016 |
| 688 |
WOUND INFECTION |
18 |
0.0016 |
| 689 |
HAEMATURIA |
56 |
0.0016 |
| 690 |
UVEITIS |
22 |
0.0016 |
| 691 |
HYPOAESTHESIA |
242 |
0.0016 |
| 692 |
ACUTE HEPATIC FAILURE |
22 |
0.0016 |
| 693 |
STAPHYLOCOCCAL INFECTION |
53 |
0.0016 |
| 694 |
FLUSHING |
163 |
0.0016 |
| 695 |
LEUKOCYTOSIS |
29 |
0.0016 |
| 696 |
NAIL DISORDER |
14 |
0.0016 |
| 697 |
DISEASE RECURRENCE |
76 |
0.0016 |
| 698 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
63 |
0.0016 |
| 699 |
LUNG INFILTRATION |
14 |
0.0016 |
| 700 |
FEELING COLD |
44 |
0.0016 |
| 701 |
TOOTH ABSCESS |
16 |
0.0016 |
| 702 |
SCIATICA |
25 |
0.0016 |
| 703 |
SINUS DISORDER |
31 |
0.0016 |
| 704 |
DRUG-INDUCED LIVER INJURY |
49 |
0.0016 |
| 705 |
JAUNDICE |
42 |
0.0016 |
| 706 |
URINARY RETENTION |
52 |
0.0016 |
| 707 |
FLUID RETENTION |
79 |
0.0016 |
| 708 |
HERNIA |
30 |
0.0015 |
| 709 |
DIZZINESS POSTURAL |
15 |
0.0015 |
| 710 |
OROPHARYNGEAL PAIN |
143 |
0.0015 |
| 711 |
BLOOD POTASSIUM INCREASED |
25 |
0.0015 |
| 712 |
UNEVALUABLE EVENT |
116 |
0.0015 |
| 713 |
COLD SWEAT |
27 |
0.0015 |
| 714 |
LIVER DISORDER |
67 |
0.0015 |
| 715 |
DERMATITIS ALLERGIC |
19 |
0.0015 |
| 716 |
INSOMNIA |
402 |
0.0015 |
| 717 |
MUSCLE ATROPHY |
19 |
0.0015 |
| 718 |
WEIGHT DECREASED |
418 |
0.0015 |
| 719 |
BODY HEIGHT DECREASED |
16 |
0.0015 |
| 720 |
HEPATIC ENZYME INCREASED |
102 |
0.0015 |
| 721 |
BLOOD PRESSURE INCREASED |
228 |
0.0015 |
| 722 |
PARAESTHESIA |
234 |
0.0015 |
| 723 |
BODY TEMPERATURE INCREASED |
30 |
0.0015 |
| 724 |
EYELID OEDEMA |
17 |
0.0015 |
| 725 |
HAEMATOCRIT DECREASED |
29 |
0.0015 |
| 726 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
15 |
0.0015 |
| 727 |
INTESTINAL OBSTRUCTION |
55 |
0.0015 |
| 728 |
SKIN LESION |
40 |
0.0015 |
| 729 |
UPPER LIMB FRACTURE |
29 |
0.0015 |
| 730 |
AUTOIMMUNE DISORDER |
14 |
0.0014 |
| 731 |
HAEMOPTYSIS |
40 |
0.0014 |
| 732 |
HIP FRACTURE |
46 |
0.0014 |
| 733 |
HYPERLIPIDAEMIA |
17 |
0.0014 |
| 734 |
BACK DISORDER |
23 |
0.0014 |
| 735 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
63 |
0.0014 |
| 736 |
ILLNESS |
143 |
0.0014 |
| 737 |
CORONARY ARTERY DISEASE |
42 |
0.0014 |
| 738 |
DERMATITIS |
29 |
0.0014 |
| 739 |
FALL |
460 |
0.0014 |
| 740 |
TOOTHACHE |
25 |
0.0014 |
| 741 |
COAGULOPATHY |
23 |
0.0014 |
| 742 |
LIVER FUNCTION TEST ABNORMAL |
40 |
0.0014 |
| 743 |
HYPERHIDROSIS |
177 |
0.0014 |
| 744 |
OSTEONECROSIS |
45 |
0.0014 |
| 745 |
HEMIPARESIS |
23 |
0.0014 |
| 746 |
DRUG INEFFECTIVE |
1786 |
0.0014 |
| 747 |
OCULAR HYPERAEMIA |
64 |
0.0013 |
| 748 |
HYPOPHAGIA |
34 |
0.0013 |
| 749 |
GASTROENTERITIS VIRAL |
24 |
0.0013 |
| 750 |
HEPATITIS |
34 |
0.0013 |
| 751 |
EYE INFECTION |
15 |
0.0013 |
| 752 |
HYPOAESTHESIA ORAL |
20 |
0.0013 |
| 753 |
BLINDNESS |
54 |
0.0013 |
| 754 |
RESTLESS LEGS SYNDROME |
24 |
0.0013 |
| 755 |
DYSGEUSIA |
98 |
0.0013 |
| 756 |
EYE SWELLING |
49 |
0.0013 |
| 757 |
INTERNAL HAEMORRHAGE |
15 |
0.0013 |
| 758 |
ABDOMINAL PAIN |
305 |
0.0013 |
| 759 |
VISION BLURRED |
180 |
0.0013 |
| 760 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
18 |
0.0013 |
| 761 |
PAIN IN JAW |
37 |
0.0013 |
| 762 |
PANCREATITIS |
69 |
0.0013 |
| 763 |
DYSURIA |
48 |
0.0013 |
| 764 |
GASTRITIS |
34 |
0.0013 |
| 765 |
LETHARGY |
74 |
0.0013 |
| 766 |
PRURITUS |
494 |
0.0013 |
| 767 |
LOSS OF CONSCIOUSNESS |
163 |
0.0013 |
| 768 |
PHOTOSENSITIVITY REACTION |
21 |
0.0013 |
| 769 |
DIPLOPIA |
33 |
0.0013 |
| 770 |
TREATMENT FAILURE |
105 |
0.0013 |
| 771 |
INFLUENZA LIKE ILLNESS |
104 |
0.0013 |
| 772 |
CARDIOVASCULAR DISORDER |
32 |
0.0013 |
| 773 |
DIABETES MELLITUS |
96 |
0.0013 |
| 774 |
APHASIA |
38 |
0.0013 |
| 775 |
HYPERSOMNIA |
36 |
0.0013 |
| 776 |
SKIN CANCER |
27 |
0.0013 |
| 777 |
INFUSION SITE PAIN |
16 |
0.0012 |
| 778 |
GALLBLADDER DISORDER |
22 |
0.0012 |
| 779 |
HEART RATE INCREASED |
122 |
0.0012 |
| 780 |
DIZZINESS |
613 |
0.0012 |
| 781 |
BALANCE DISORDER |
106 |
0.0012 |
| 782 |
WHITE BLOOD CELL COUNT INCREASED |
47 |
0.0012 |
| 783 |
ELECTROCARDIOGRAM QT PROLONGED |
44 |
0.0012 |
| 784 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
220 |
0.0012 |
| 785 |
DYSPEPSIA |
120 |
0.0012 |
| 786 |
APHONIA |
17 |
0.0012 |
| 787 |
LYMPHADENOPATHY |
43 |
0.0012 |
| 788 |
BLOOD PRESSURE ABNORMAL |
24 |
0.0012 |
| 789 |
FEELING JITTERY |
23 |
0.0012 |
| 790 |
ORAL PAIN |
27 |
0.0012 |
| 791 |
MALAISE |
528 |
0.0012 |
| 792 |
FUNGAL INFECTION |
40 |
0.0012 |
| 793 |
DEAFNESS |
31 |
0.0012 |
| 794 |
SENSORY DISTURBANCE |
19 |
0.0012 |
| 795 |
PRODUCT DOSE OMISSION |
77 |
0.0012 |
| 796 |
PARAESTHESIA ORAL |
17 |
0.0012 |
| 797 |
GINGIVAL BLEEDING |
16 |
0.0012 |
| 798 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
15 |
0.0012 |
| 799 |
METASTASES TO BONE |
19 |
0.0012 |
| 800 |
DISTURBANCE IN ATTENTION |
62 |
0.0011 |
| 801 |
DISCOMFORT |
70 |
0.0011 |
| 802 |
SKIN HAEMORRHAGE |
17 |
0.0011 |
| 803 |
NECK PAIN |
64 |
0.0011 |
| 804 |
PULMONARY MASS |
17 |
0.0011 |
| 805 |
INTERCEPTED PRODUCT PREPARATION ERROR |
14 |
0.0011 |
| 806 |
THERAPEUTIC RESPONSE UNEXPECTED |
51 |
0.0011 |
| 807 |
MELAENA |
25 |
0.0011 |
| 808 |
ERYTHEMA |
232 |
0.0011 |
| 809 |
SLEEP DISORDER |
79 |
0.0011 |
| 810 |
VISUAL ACUITY REDUCED |
37 |
0.0011 |
| 811 |
DISORIENTATION |
44 |
0.0011 |
| 812 |
CHRONIC KIDNEY DISEASE |
84 |
0.0011 |
| 813 |
ANOSMIA |
16 |
0.0011 |
| 814 |
GASTROINTESTINAL HAEMORRHAGE |
92 |
0.0011 |
| 815 |
LYMPHOMA |
17 |
0.0011 |
| 816 |
MUSCULAR WEAKNESS |
125 |
0.0011 |
| 817 |
EAR INFECTION |
29 |
0.0011 |
| 818 |
TOXICITY TO VARIOUS AGENTS |
183 |
0.0011 |
| 819 |
GAIT INABILITY |
36 |
0.0011 |
| 820 |
HAEMORRHOIDS |
21 |
0.0011 |
| 821 |
BLOOD UREA INCREASED |
18 |
0.0011 |
| 822 |
ABDOMINAL DISTENSION |
112 |
0.0011 |
| 823 |
RASH ERYTHEMATOUS |
51 |
0.0011 |
| 824 |
LIMB DISCOMFORT |
33 |
0.0011 |
| 825 |
ABSCESS |
17 |
0.0011 |
| 826 |
BEDRIDDEN |
14 |
0.0011 |
| 827 |
POLLAKIURIA |
44 |
0.0011 |
| 828 |
URTICARIA |
176 |
0.0010 |
| 829 |
EYE PRURITUS |
35 |
0.0010 |
| 830 |
CEREBROVASCULAR ACCIDENT |
176 |
0.0010 |
| 831 |
PAIN |
635 |
0.0010 |
| 832 |
CONTUSION |
99 |
0.0010 |
| 833 |
HEART RATE DECREASED |
36 |
0.0010 |
| 834 |
LUNG NEOPLASM MALIGNANT |
42 |
0.0010 |
| 835 |
CENTRAL NERVOUS SYSTEM LESION |
14 |
0.0010 |
| 836 |
GASTROOESOPHAGEAL REFLUX DISEASE |
82 |
0.0010 |
| 837 |
VERTIGO |
62 |
0.0010 |
| 838 |
DIABETES MELLITUS INADEQUATE CONTROL |
18 |
0.0010 |
| 839 |
HEAD INJURY |
32 |
0.0010 |
| 840 |
PRODUCT PRESCRIBING ERROR |
24 |
0.0010 |
| 841 |
HYPOACUSIS |
43 |
0.0010 |
| 842 |
PAIN IN EXTREMITY |
292 |
0.0010 |
| 843 |
ABDOMINAL DISCOMFORT |
166 |
0.0010 |
| 844 |
EATING DISORDER |
21 |
0.0010 |
| 845 |
DRUG DOSE OMISSION |
163 |
0.0010 |
| 846 |
RETCHING |
21 |
0.0010 |
| 847 |
VISUAL IMPAIRMENT |
122 |
0.0010 |
| 848 |
URINARY INCONTINENCE |
29 |
0.0010 |
| 849 |
SEIZURE |
113 |
0.0010 |
| 850 |
PARALYSIS |
14 |
0.0010 |
| 851 |
EAR PAIN |
19 |
0.0010 |
| 852 |
INJECTION SITE REACTION |
67 |
0.0010 |
| 853 |
UNRESPONSIVE TO STIMULI |
25 |
0.0010 |
| 854 |
PHOTOPHOBIA |
18 |
0.0010 |
| 855 |
PERICARDITIS |
16 |
0.0010 |
| 856 |
CONDITION AGGRAVATED |
288 |
0.0009 |
| 857 |
INTENTIONAL DOSE OMISSION |
27 |
0.0009 |
| 858 |
EYE DISORDER |
31 |
0.0009 |
| 859 |
PALPITATIONS |
110 |
0.0009 |
| 860 |
ABDOMINAL PAIN UPPER |
193 |
0.0009 |
| 861 |
SWELLING FACE |
61 |
0.0009 |
| 862 |
SKIN DISCOLOURATION |
43 |
0.0009 |
| 863 |
MYALGIA |
159 |
0.0009 |
| 864 |
DYSPHAGIA |
88 |
0.0009 |
| 865 |
TINNITUS |
42 |
0.0009 |
| 866 |
PHARYNGEAL OEDEMA |
14 |
0.0009 |
| 867 |
MYOCARDIAL INFARCTION |
158 |
0.0009 |
| 868 |
MUSCULOSKELETAL DISCOMFORT |
15 |
0.0009 |
| 869 |
CHOKING |
17 |
0.0009 |
| 870 |
FEELING ABNORMAL |
208 |
0.0009 |
| 871 |
MUSCLE TIGHTNESS |
14 |
0.0009 |
| 872 |
MUSCULOSKELETAL PAIN |
45 |
0.0009 |
| 873 |
NEOPLASM MALIGNANT |
57 |
0.0009 |
| 874 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
41 |
0.0009 |
| 875 |
MENTAL DISORDER |
37 |
0.0008 |
| 876 |
BLOOD SODIUM DECREASED |
16 |
0.0008 |
| 877 |
SWELLING |
79 |
0.0008 |
| 878 |
MUSCULOSKELETAL DISORDER |
16 |
0.0008 |
| 879 |
FEEDING DISORDER |
17 |
0.0008 |
| 880 |
DRY MOUTH |
68 |
0.0008 |
| 881 |
INCREASED APPETITE |
16 |
0.0008 |
| 882 |
ARTHRALGIA |
348 |
0.0008 |
| 883 |
RESPIRATORY ARREST |
23 |
0.0008 |
| 884 |
BLOOD PRESSURE FLUCTUATION |
20 |
0.0008 |
| 885 |
SKIN EXFOLIATION |
70 |
0.0008 |
| 886 |
RASH MACULAR |
29 |
0.0008 |
| 887 |
MEDICATION ERROR |
46 |
0.0008 |
| 888 |
OSTEOARTHRITIS |
35 |
0.0008 |
| 889 |
SOMNOLENCE |
166 |
0.0008 |
| 890 |
INTERVERTEBRAL DISC PROTRUSION |
18 |
0.0008 |
| 891 |
UNDERDOSE |
60 |
0.0008 |
| 892 |
JOINT SWELLING |
99 |
0.0008 |
| 893 |
THERAPY CESSATION |
42 |
0.0008 |
| 894 |
PAIN OF SKIN |
22 |
0.0008 |
| 895 |
RECTAL HAEMORRHAGE |
35 |
0.0008 |
| 896 |
MEMORY IMPAIRMENT |
111 |
0.0008 |
| 897 |
ASTHMA |
91 |
0.0008 |
| 898 |
METASTASES TO LIVER |
14 |
0.0008 |
| 899 |
INFLAMMATION |
41 |
0.0008 |
| 900 |
GAIT DISTURBANCE |
152 |
0.0008 |
| 901 |
POOR QUALITY SLEEP |
17 |
0.0008 |
| 902 |
ARTHRITIS |
61 |
0.0008 |
| 903 |
LIMB INJURY |
21 |
0.0008 |
| 904 |
PALLOR |
21 |
0.0008 |
| 905 |
DYSARTHRIA |
29 |
0.0008 |
| 906 |
HEADACHE |
480 |
0.0008 |
| 907 |
STEVENS-JOHNSON SYNDROME |
17 |
0.0008 |
| 908 |
PANCREATIC CARCINOMA |
22 |
0.0008 |
| 909 |
WEIGHT INCREASED |
170 |
0.0008 |
| 910 |
ARTHROPATHY |
42 |
0.0008 |
| 911 |
HEART RATE IRREGULAR |
17 |
0.0008 |
| 912 |
IRRITABLE BOWEL SYNDROME |
16 |
0.0007 |
| 913 |
DRUG EFFECT INCOMPLETE |
27 |
0.0007 |
| 914 |
HAEMATOCHEZIA |
41 |
0.0007 |
| 915 |
FOOT FRACTURE |
14 |
0.0007 |
| 916 |
HAEMORRHAGE |
76 |
0.0007 |
| 917 |
FEELING HOT |
44 |
0.0007 |
| 918 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
21 |
0.0007 |
| 919 |
DRY SKIN |
95 |
0.0007 |
| 920 |
CHOLELITHIASIS |
23 |
0.0007 |
| 921 |
BURNING SENSATION |
49 |
0.0007 |
| 922 |
PROSTATE CANCER |
56 |
0.0007 |
| 923 |
AGITATION |
51 |
0.0007 |
| 924 |
CONTRAINDICATED PRODUCT ADMINISTERED |
21 |
0.0007 |
| 925 |
METABOLIC ACIDOSIS |
22 |
0.0007 |
| 926 |
INJECTION SITE RASH |
21 |
0.0007 |
| 927 |
GASTRIC DISORDER |
23 |
0.0007 |
| 928 |
DRY EYE |
33 |
0.0007 |
| 929 |
MENTAL IMPAIRMENT |
16 |
0.0007 |
| 930 |
RESTLESSNESS |
24 |
0.0007 |
| 931 |
ANGIOEDEMA |
29 |
0.0007 |
| 932 |
MUSCLE TWITCHING |
15 |
0.0007 |
| 933 |
LACTIC ACIDOSIS |
21 |
0.0006 |
| 934 |
SURGERY |
38 |
0.0006 |
| 935 |
BLOOD GLUCOSE INCREASED |
122 |
0.0006 |
| 936 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
14 |
0.0006 |
| 937 |
AMNESIA |
42 |
0.0006 |
| 938 |
WOUND |
18 |
0.0006 |
| 939 |
FLATULENCE |
36 |
0.0006 |
| 940 |
NEPHROLITHIASIS |
29 |
0.0006 |
| 941 |
SPEECH DISORDER |
33 |
0.0006 |
| 942 |
TYPE 2 DIABETES MELLITUS |
21 |
0.0006 |
| 943 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
44 |
0.0006 |
| 944 |
MOBILITY DECREASED |
44 |
0.0006 |
| 945 |
EYE PAIN |
34 |
0.0006 |
| 946 |
HYPOTHYROIDISM |
19 |
0.0006 |
| 947 |
GASTRIC CANCER |
15 |
0.0006 |
| 948 |
HAEMATEMESIS |
15 |
0.0006 |
| 949 |
DIABETIC KETOACIDOSIS |
14 |
0.0006 |
| 950 |
NERVOUSNESS |
30 |
0.0006 |
| 951 |
AGGRESSION |
28 |
0.0006 |
| 952 |
OSTEOPOROSIS |
23 |
0.0006 |
| 953 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
112 |
0.0006 |
| 954 |
BLISTER |
31 |
0.0006 |
| 955 |
DYSSTASIA |
16 |
0.0005 |
| 956 |
COMA |
26 |
0.0005 |
| 957 |
ERECTILE DYSFUNCTION |
14 |
0.0005 |
| 958 |
RENAL INJURY |
16 |
0.0005 |
| 959 |
HOT FLUSH |
40 |
0.0005 |
| 960 |
ROAD TRAFFIC ACCIDENT |
22 |
0.0005 |
| 961 |
ALOPECIA |
102 |
0.0005 |
| 962 |
SWOLLEN TONGUE |
16 |
0.0005 |
| 963 |
EYE IRRITATION |
29 |
0.0005 |
| 964 |
RHABDOMYOLYSIS |
21 |
0.0005 |
| 965 |
ANXIETY |
142 |
0.0005 |
| 966 |
DEPRESSION |
112 |
0.0005 |
| 967 |
INJECTION SITE ERYTHEMA |
59 |
0.0005 |
| 968 |
HYPOGLYCAEMIA |
23 |
0.0005 |
| 969 |
DEPRESSED MOOD |
25 |
0.0005 |
| 970 |
BREAST CANCER |
43 |
0.0005 |
| 971 |
IMPAIRED HEALING |
15 |
0.0005 |
| 972 |
MUSCULOSKELETAL STIFFNESS |
40 |
0.0005 |
| 973 |
BLOOD CHOLESTEROL INCREASED |
21 |
0.0005 |
| 974 |
ECZEMA |
23 |
0.0004 |
| 975 |
NO ADVERSE EVENT |
76 |
0.0004 |
| 976 |
DYSKINESIA |
17 |
0.0004 |
| 977 |
PRODUCT STORAGE ERROR |
36 |
0.0004 |
| 978 |
DRUG INTERACTION |
64 |
0.0004 |
| 979 |
HALLUCINATION |
29 |
0.0004 |
| 980 |
IRRITABILITY |
23 |
0.0004 |
| 981 |
INCORRECT DOSE ADMINISTERED |
84 |
0.0004 |
| 982 |
BLOOD GLUCOSE DECREASED |
14 |
0.0003 |
| 983 |
INJURY |
20 |
0.0003 |
| 984 |
ACCIDENTAL EXPOSURE TO PRODUCT |
29 |
0.0003 |
| 985 |
ILL-DEFINED DISORDER |
17 |
0.0003 |
| 986 |
MIGRAINE |
26 |
0.0003 |
| 987 |
INJECTION SITE BRUISING |
21 |
0.0003 |
| 988 |
DRUG EFFECT DECREASED |
14 |
0.0003 |
| 989 |
ACNE |
19 |
0.0003 |
| 990 |
PRODUCT QUALITY ISSUE |
31 |
0.0002 |
| 991 |
PSORIASIS |
25 |
0.0002 |
| 992 |
INJECTION SITE PAIN |
58 |
0.0002 |
| 993 |
OVERDOSE |
33 |
0.0002 |